Standard dosing regimen of liposomal amphotericin B is as effective as a high-loading dose for patients with invasive

Related Experiment Video

Updated: Jul 9, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Cornelia Lass-Flörl1

  • 1Innsbruck Medical University, Department of Hygiene, Microbiology and Social Medicine, Section of Hygiene and Medical Microbiology, Fritz Pregl Str. 3/III, 6020 Innsbruck, Austria. cornelia.lass-floerl@i-med.ac.at

Expert Review of Anti-Infective Therapy
|November 28, 2007
PubMed

Insights

This study compared high-loading versus standard doses of liposomal amphotericin B (L-AMB) for invasive mold infections. Results showed no difference in efficacy, but higher doses increased toxicity, supporting routine L-AMB use.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Invasive mold infections pose significant risks for immunocompromised patients.
  • Liposomal amphotericin B (L-AMB) is a key antifungal agent.
  • Optimal L-AMB dosing for mold infections remains debated.

Purpose of the Study:

  • To compare a high-loading dose regimen with standard dosing of L-AMB for primary mold infection therapy.
  • To evaluate the efficacy and safety of different L-AMB dosing strategies.
  • To identify factors influencing survival in patients with invasive mold infections.

Main Methods:

  • A randomized trial (AmBiLoad) compared high-loading versus standard L-AMB doses.
  • Patients with primary mold infections were enrolled.
  • Outcomes included treatment response, survival, and adverse events like nephrotoxicity and hypokalemia.

Main Results:

  • No significant difference in treatment response was observed between the high-loading and standard L-AMB dose groups.
  • The 10-mg/kg daily dose of L-AMB was associated with increased rates of nephrotoxicity and hypokalemia.
  • Uncontrolled malignancy and allogeneic stem cell transplantation were linked to poorer survival outcomes.

Conclusions:

  • The study supports the routine application of liposomal amphotericin B for invasive mold infections.
  • Standard L-AMB dosing appears sufficient, with higher doses potentially increasing toxicity.
  • Host factors like malignancy and stem cell transplant status are critical for patient survival.

More Related Videos

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...